- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06139965
Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
November 15, 2023 updated by: Gokce Yagmur Gunes Gencer, Akdeniz University
The aim of this study is to investigate the Turkish adaptation of the Comprehensive Coordination Scale and its validity and reliability in Parkinson's patients.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
A Turkish version of the Comprehensive Coordination Scale will be made.
Then, Comprehensive Coordination Scale, 9-Hole Peg Test, Timed Up and Go Test, Berg Balance Scale, Functional Reaching Test and Modified Hoehn and Yahr Scale will be applied to patients with Parkinson's, respectively.
In order to determine the reliability of the scale, only the "Comprehensive Coordination Scale" will be video recorded during the first evaluation and inter-rater reliability will be performed by another physiotherapist.
For test-retest reliability, patients will be evaluated seven days later by the first physiotherapist who made the evaluation by watching the video again.
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Gökçe Yağmur Güneş Gencer, Assist.Prof.
- Phone Number: 4187 +90 242 227 4400
- Email: gokcegunes@akdeniz.edu.tr
Study Contact Backup
- Name: Lütfiye Akkurt, Assist.Prof.
- Phone Number: 0902742600043
- Email: fzt.lutfiyeakkurt@gmail.com
Study Locations
-
-
-
Antalya, Turkey, 07070
- Recruiting
- Gökçe Yağmur Güneş Gencer
-
Contact:
- Gokce Yagmur Gunes Gencer
- Phone Number: +905369355050
- Email: g.yagmur.g@gmail.com
-
Antalya, Turkey
- Recruiting
- Ozel Termessos Hastanesi
-
Contact:
- Nazan Ş Erdem, MD
- Phone Number: +90242 212 18 18
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Parkinson's patients
Description
Inclusion Criteria:
- Diagnosed with Parkinson's,
- Mini mental test score over 24,
- Those who have not experienced any serious neurological or orthopedic problems in the last 6 months,
- İndividuals who agreed to participate in the study
Exclusion Criteria:
- Mini mental test score <24,
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comprehensive Coordination Scale
Time Frame: Baseline (First assessment)
|
The Comprehensive Coordination Scale (CCS) is a measure of coordination of multiple body segments at both motor performance (endpoint movement) and quality of movement (joint rotations and interjoint coordination) levels based on observational kinematics.
|
Baseline (First assessment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
9 Hole Peg Test
Time Frame: Baseline (First assessment)
|
The Nine-Hole Peg Test (9-HPT) is a standardized, quantitative assessment used to measure finger dexterity.
|
Baseline (First assessment)
|
|
Timed Up and Go Test (TUG)
Time Frame: Baseline (First assessment)
|
The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults.
|
Baseline (First assessment)
|
|
Berg Balance Test
Time Frame: Baseline (First assessment)
|
The Berg Balance Scale (BBS) is a 14-item objective measure that assesses static balance and fall risk in adults.
|
Baseline (First assessment)
|
|
Functional Reach Test
Time Frame: Baseline (First assessment)
|
The Functional Reach Test assesses a patient's stability by measuring the maximum distance an individual can reach forward while standing in a fixed position.
|
Baseline (First assessment)
|
|
Modified Hoehn and Yahr Scale
Time Frame: Baseline (First assessment)
|
The Hoehn and Yahr scale is used to describe the symptom progression of Parkinson disease
|
Baseline (First assessment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gökçe Yağmur Güneş Gencer, Assist.Prof., Akdeniz University
- Study Chair: Lütfiye Akkurt, Assist.Prof., Kütahya Health Sciences University
- Study Chair: Hayri Aktaş, MSc, Akdeniz University
- Study Chair: Nazan Ş Erdem, MD, Ozel Termessos Hastanesi
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 5, 2023
Primary Completion (Estimated)
January 5, 2024
Study Completion (Estimated)
January 30, 2024
Study Registration Dates
First Submitted
November 15, 2023
First Submitted That Met QC Criteria
November 15, 2023
First Posted (Estimated)
November 20, 2023
Study Record Updates
Last Update Posted (Estimated)
November 20, 2023
Last Update Submitted That Met QC Criteria
November 15, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KAEK-633
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Validity and Reliability
-
University of GaziantepCompletedTrapeziometacarpal ArthrosisTurkey
-
Pamukkale UniversityCompleted
-
Alanya Alaaddin Keykubat UniversityNot yet recruitingTemporomandibular Joint Dysfunction | Reliability | Validity | Craniocervical DysfunctionTurkey
-
Alanya Alaaddin Keykubat UniversityNot yet recruitingNeck Pain | Craniocervical DisfunctionTurkey
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingPhysical Activity | Children
-
Trakya UniversityBartın UnıversityCompleted
-
Trakya UniversityCompletedTherapeutic AgalactiaTurkey
-
Tokat Gaziosmanpasa UniversityCompleted
-
Kutahya Health Sciences UniversityCompletedChronic Low-back Pain | Health Personnel AttitudeTurkey
-
Kutahya Health Sciences UniversityCompleted